Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium injection for acute lung injury with systemic inflammatory response syndrome
CTR20132706Phase 3Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sivelestat in acute lung injury (ALI), sponsored by Shanghai Institute of Materia Medica. Started May 2014; status: completed.
02
Drugs
sivelestat
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on CTR20132706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132706.